cimadronate has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amano, S; Inagaki, Y; Kikuchi, S; Ohno, S; Okamoto, T; Takeuchi, M; Yamagishi, S; Yoshimura, A | 1 |
1 other study(ies) available for cimadronate and Angiogenesis, Pathologic
Article | Year |
---|---|
Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro.
Topics: Animals; Cells, Cultured; Diphosphonates; Endothelial Growth Factors; Endothelium, Vascular; Flavonoids; Glycation End Products, Advanced; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Neovascularization, Pathologic; NF-kappa B; Polyisoprenyl Phosphates; Promoter Regions, Genetic; Sesquiterpenes; Transcription Factor AP-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |